• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New Strategy Enables Oxidation-Free, Efficient Oligonucleotide Synthesis

Bioengineer by Bioengineer
July 29, 2026
in Biology
Reading Time: 2 mins read
0
New Strategy Enables Oxidation-Free, Efficient Oligonucleotide Synthesis
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Efficient oligonucleotide synthesis is the bottleneck behind many modern applications, from molecular diagnostics to nucleic acid therapeutics. The current workhorse approach—P(III)-phosphoramidite chemistry—delivers speed and reliability, yet it demands an oxidation step after nearly every nucleotide coupling cycle. That requirement adds reagents, increases exposure to moisture-sensitive intermediates, and slows automated workflows.

Pentavalent phosphorus (P(V)) chemistry has long been viewed as an alternative because it can, in principle, form nucleotide linkages without the repetitive oxidation routine. But earlier attempts struggled with practical chemistry: unstable intermediates, slow couplings, harsh deprotection conditions, and failures during chain elongation all prevented widespread replacement of P(III) strategies.

Now a team led by Associate Professor Noriko Saito-Tarashima at Tokushima University, working with doctoral researcher Nana Mihara, revisits the historical promise of P(V) chemistry using a modern design concept: stable nucleoside 3′-phosphorofluoridates (P(V)–F) as building blocks. Their study appears online on June 19, 2026, and is published in the Journal of the American Chemical Society (JACS), dated July 1, 2026.

The central idea is to remove oxidation from the cycle by using P(V)–F monomers that support neutral chain growth. This “oxidation-free” design targets three practical constraints at once: isolable, storage-stable monomers; coupling performance comparable to phosphoramidites; and reliable propagation of the growing oligonucleotide chain.

To make the approach work, the researchers activate the P(V)–F linkage with a silicon-based additive. By screening reaction bases and silicon-containing activators, they identify conditions that enable efficient dinucleotide formation. In a model system, the coupling yield reaches a quantitative level, indicating strong reactivity under synthetically practical conditions.

Speed matters as well: when benchmarked against standard P(III) phosphoramidite coupling, the P(V)–F system delivers faster assembly. That kinetic advantage suggests a path toward more efficient nucleotide cycles without sacrificing product quality.

Crucially, the method is not confined to solution-phase chemistry. The team adapts the P(V)–F coupling chemistry to automated solid-phase synthesis using a standard DNA/RNA synthesizer. Initial trials showed inconsistency, but targeted optimizations enabled successful automated oligonucleotide production—an essential step for real-world manufacturing.

Overall, the work positions P(V)–F as a complementary platform rather than a sudden replacement. By addressing oxidation overhead and improving robustness, the strategy could streamline the next generation of oligonucleotide manufacturing, accelerating research timelines and supporting future diagnostic and therapeutic pipelines.

Subject of Research: Oligonucleotide synthesis (chemical nucleic acid assembly)

Article Title: Nucleoside 3′-Phosphorofluoridates for P(V)-Based Oligonucleotide Synthesis

News Publication Date: 19-Jun-2026 (online availability); published 01-Jul-2026

Web References: https://pubs.acs.org/doi/10.1021/jacs.6c04623

References: DOI: 10.1021/jacs.6c04623

Image Credits: Credit: Associate Professor Noriko Saito-Tarashima from Tokushima University, Japan

Keywords: P(V) chemistry, oxidation-free synthesis, nucleoside 3′-phosphorofluoridates, oligonucleotides, silicon-mediated activation, automated solid-phase synthesis, phosphoramidite replacement, JACS

Tags: automated oligonucleotide manufacturingchain elongation efficiencymodern P(V) chemistry innovationsmoisture-sensitive intermediatesmolecular diagnosticsnucleic acid therapeuticsoxidation-free nucleotide synthesis strategyoxidation-free oligonucleotide synthesisP(V)-phosphorofluoridatesphosphoramidite chemistry limitationsreliable nucleic acid chain assemblystable nucleotide linkage formation

Share12Tweet7Share2ShareShareShare1

Related Posts

How Organisms Balance Memory, Thought, and Sensing Costs

How Organisms Balance Memory, Thought, and Sensing Costs

July 29, 2026

Merging Metasurfaces with Image Sensors Enables Ultra-Compact Optoelectronics

July 28, 2026

Software Enables Researchers to Decode Lymphoma’s Cellular Architecture

July 28, 2026

Elephant Vaccine Early Results Show Protection Against Deadly Virus

July 28, 2026

POPULAR NEWS

  • Prenatal biometry predicts optimal endotracheal tube depth in very low-birthweight infants

    29 shares
    Share 12 Tweet 7
  • Bioengineered Approaches to Probe and Modulate the Aging Immune System

    29 shares
    Share 12 Tweet 7
  • Pusan National and Chung-Ang Develop Next-Gen Self-Renewing Air Filter Coating

    29 shares
    Share 12 Tweet 7
  • CHEST Critical Care Achieves First Ever Impact Factor

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Prenatal biometry predicts optimal endotracheal tube depth in very low-birthweight infants

Bioengineered Approaches to Probe and Modulate the Aging Immune System

Pusan National and Chung-Ang Develop Next-Gen Self-Renewing Air Filter Coating

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.